Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ - 07852 (844)446-6979
Published January 6, 2021 · Recall initiated: December 17, 2020
Summary
FDA records drug Class II recall D-0177-2021, published January 6, 2021 and initiated December 17, 2020. Recalling firm: Imprimis NJOF, LLC; Status: Terminated; Reported quantity: 6520 vials; Lot: Lot#: 20JUN010, Exp 5/12/21. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of assurance of sterility: 13 vials were discovered to have faulty crimps.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Imprimis NJOF, LLC
- Distributor
- U.S.A. Nationwide
- Lot
- Lot#: 20JUN010, Exp 5/12/21
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection,January 14, 2026
- FDADexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC,January 14, 2026
- FDATri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, ImprimisJanuary 14, 2026
- FDAKlarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug,November 26, 2025
- FDANeostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes, Hospital/Office Use Only. USJanuary 6, 2021
- FDAAscend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx OnlyJanuary 6, 2021
Questions about this recall
Was Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ - 07852 (844)446-6979 recalled?
Yes. FDA published recall D-0177-2021 on January 6, 2021. Reported hazard: Lack of assurance of sterility: 13 vials were discovered to have faulty crimps.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit